Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Free Cash Flow (2016 - 2021)

Phio Pharmaceuticals' Free Cash Flow history spans 10 years, with the latest figure at -$2.5 million for Q4 2021.

  • For Q4 2021, Free Cash Flow rose 5.83% year-over-year to -$2.5 million; the TTM value through Dec 2021 reached -$11.9 million, down 35.01%, while the annual FY2025 figure was -$8.0 million, 12.34% down from the prior year.
  • Free Cash Flow reached -$2.5 million in Q4 2021 per PHIO's latest filing, up from -$2.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.8 million in Q4 2018 to a low of -$3.3 million in Q1 2021.
  • Average Free Cash Flow over 5 years is -$2.3 million, with a median of -$2.2 million recorded in 2017.
  • Peak YoY movement for Free Cash Flow: skyrocketed 31.92% in 2018, then plummeted 61.56% in 2021.
  • A 5-year view of Free Cash Flow shows it stood at -$2.2 million in 2017, then grew by 20.45% to -$1.8 million in 2018, then plummeted by 47.63% to -$2.6 million in 2019, then decreased by 1.51% to -$2.6 million in 2020, then increased by 5.83% to -$2.5 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Free Cash Flow are -$2.5 million (Q4 2021), -$2.9 million (Q3 2021), and -$3.3 million (Q2 2021).